Stericycle, Inc. Reports Results for Fourth Quarter and Full Year Ended 2012

Before you go, we thought you'd like these...
Before you go close icon

Stericycle, Inc. Reports Results for Fourth Quarter and Full Year Ended 2012

LAKE FOREST, Ill.--(BUSINESS WIRE)-- Stericycle, Inc. (Nasdaq: SRCL), today reported financial results for the fourth quarter and full year of 2012.


Revenues for the quarter ended December 31, 2012 were $503.6 million, up 12.8% from $446.6 million in the fourth quarter last year. Acquisitions contributed approximately $31.1 million to the current period's growth in revenues. Revenues increased 13.3% compared to the prior period when adjusted for unfavorable foreign exchange impacts of $2.3 million. Gross profit was $227.0 million, up 12.6% from $201.5 million in the fourth quarter last year. Gross profit as a percent of revenue was 45.1% compared with 45.1% in the fourth quarter of 2011.

Net income attributable to Stericycle for the fourth quarter of 2012 was $70.1 million or $0.80 per diluted share compared with $64.3 million or $0.74 per diluted share for the fourth quarter of 2011. Net income attributable to Stericycle for the fourth quarters of 2012 and 2011 includes acquisition expenses, adjustments of contingent consideration to fair value, restructuring and plant closure costs, loss on the sale of business, litigation settlement expense, and other items. Excluding the effect of these items, non-GAAP earnings per diluted share were $0.88 for the current quarter (see table below). Non-GAAP earnings per diluted share increased 15.1% from non-GAAP earnings per diluted share of $0.76 in the fourth quarter of 2011.

FULL-YEAR RESULTS

Revenues for the full year 2012 were $1.91 billion, up 14.1% from $1.68 billion in 2011. Acquisitions contributed approximately $140.3 million to the current year's growth in revenues. Revenues increased 15.4% compared to the prior year when adjusted for unfavorable foreign exchange impacts of $21.8 million. Gross profit was $857.3 million, up 12.7% from $760.7 million in 2011. Gross profit as a percent of revenue was 44.8% compared with 45.4% in 2011. Earnings per diluted share increased 14.6% to $3.08 in 2012 from $2.69 in 2011. Non-GAAP earnings per diluted share, when adjusted for various items, increased 15.4% to $3.30 from $2.86 (see table below).

 

Table to reconcile non-GAAP EPS to GAAP EPS:

   

Three months ended December 31,

Year ended December 31,

  Change Change  ChangeChange
  2012 2011 $ % 2012 2011 $ %
GAAP EPS$0.80$0.74$0.068.2%$3.08$2.69$0.3914.6%
 
Acquisition expenses/Fair Value0.02(0.01)0.100.12
 
Restructuring/Plant Closure0.010.030.040.04
 
Loss/(Gain) on Sale0.040.00
 
Litigation Expense0.040.010.040.01
 
Acceleration of Term Loan Fees0.000.01
 
Non-GAAP EPS (adjusted)$0.88$0.76$0.1215.1%$3.30$2.86$0.4415.4%
* In accordance with U.S. generally accepted accounting principles (GAAP), reported earnings per share include the after-tax impact of the items identified in this table. For internal purposes, including the determination of management compensation, the Company excludes these items from results when evaluating operating performance. This table and the Company's internal use of non-GAAP earnings per share are not intended to imply, and should not be interpreted as implying, that non-GAAP earnings per share is a better measure of performance than GAAP earnings per share.
 

Cash flow from operations was $387.4 million for the full year of 2012.

For more information about Stericycle, please visit our website at www.stericycle.com.

Safe Harbor Statement : Statements in this press release may contain forward-looking statements that involve risks and uncertainties, some of which are beyond our control (for example, general economic conditions). Our actual results could differ significantly from the results described in the forward-looking statements. Factors that could cause such differences include changes in governmental regulation of medical waste collection and treatment and increases in transportation and other operating costs, as well as the other factors described in our filings with the U.S. Securities and Exchange Commission. As a result, past financial performance should not be considered a reliable indicator of future performance, and investors should not use historical trends to anticipate future results or trends. We make no commitment to disclose any subsequent revisions to forward-looking statements.

Conference call to be held February 6, 2013 4:00 p.m. Central time - Dial 866-516-6872 at least 5 minutes before start time. If you are unable to participate on the call, a replay will be available through March 5th by dialing 855-859-2056, access code 86463685. To hear a live simulcast of the call over the internet on www.earnings.com, or to access an audio archive of the call, go to the Investors page on Stericycle's website at www.stericycle.com.

         
STERICYCLE, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(IN THOUSANDS EXCEPT FOR SHARE AND PER SHARE DATA)
 
Three Months EndedYears Ended
December 31,December 31,
2012201120122011
(Unaudited)(Unaudited)(Audited)
$ % of Rev$ % of Rev$ % of Rev $ % of Rev
 
Revenues$503,638100.0%$446,557100.0%$1,913,149100.0%$1,676,048100.0%
 
Cost of revenues264,54152.5%234,34252.5%1,011,08152.8%874,11552.2%
Depreciation - cost of revenues12,0092.4%10,6972.4%44,6312.3%41,1352.5%
Restructuring costs132  0.0%-  0.0%132  0.0%54  0.0%
 
Gross profit226,95645.1%201,51845.1%857,30544.8%760,74445.4%
 
Selling, general and administrative expenses86,49617.2%76,65317.2%327,13117.1%291,46817.4%
Depreciation - SG&A2,7060.5%2,1950.5%9,5980.5%8,6420.5%
Amortization6,379  1.3%5,167  1.2%22,054  1.2%16,269  1.0%
 
Total SG&A expense and amortization95,581  19.0%84,015  18.8%358,783  18.8%316,379  18.9%
 
Income from operations before
acquisition, integration, and other expenses131,37526.1%117,50326.3%498,52226.1%444,36526.5%
 
Acquisition expenses1,7070.3%2,3100.5%7,9200.4%16,7041.0%
Restructuring costs and plant closure expense1,8010.4%3,9890.9%5,2010.3%5,0210.3%
Litigation settlement6,0501.2%7250.2%6,0500.3%1,1850.1%
Loss/ (gain) on sale of businesses-0.0%(304)-0.1%4,8670.3%190.0%
Change in fair value of contingent consideration1610.0%(5,081)-1.1%7520.0%(7,221)-0.4%
Integration expenses1,356  0.3%480  0.1%4,896  0.3%4,346  0.3%
 
Income from operations120,30023.9%115,38425.8%468,83624.5%424,31125.3%
 
Other income (expense):
Interest income710.0%3150.1%4040.0%7990.0%
Interest expense(13,077)-2.6%(13,018)-2.9%(51,674)-2.7%(49,431)-2.9%
Other expense, net187  0.0%(1,696) -0.4%(369) 0.0%(3,355) -0.2%
 
Total other income (expense)(12,819) -2.5%(14,399) -3.2%(51,639) -2.7%(51,987) -3.1%
 
Income before income taxes107,48121.3%100,98522.6%417,19721.8%372,32422.2%
 
Income tax expense36,973  7.3%35,862 Read Full Story

Want more news like this?

Sign up for Finance Report by AOL and get everything from business news to personal finance tips delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.

From Our Partners

Gift Finder Promo
More to Explore
Fri, Dec 09
Set Your Location
City, State, or Zip